Compare Stocks: HIMS, DGX, GH, and TEM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$251.87 -0.4%	$238.53	$171.18 ▼ $256.99	$27.83B	0.54	1.05 million shs	919,588 shs
GH Guardant Health	$178.80 -3.5%	$169.71	$74.55 ▼ $191.05	$24.87B	1.58	1.79 million shs	1.50 million shs
HIMS Hims & Hers Health	$27.59 -7.0%	$29.04	$13.74 ▼ $48.34	$6.92B	2.44	9.80 million shs	10.84 million shs
TEM Tempus AI	$72.22 -7.2%	$70.69	$40.77 ▼ $90.53	$14.05B	3.54	6.20 million shs	10.43 million shs

10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	-0.42%	+4.30%	+7.93%	+8.00%	+44.01%
GH Guardant Health	-3.51%	+5.75%	+0.25%	+10.38%	+147.41%
HIMS Hims & Hers Health	-7.04%	-0.39%	-7.30%	-0.71%	-40.74%
TEM Tempus AI	-7.22%	+6.82%	-11.82%	+64.62%	-18.71%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$251.87 -0.4%	$238.53	$171.18 ▼ $256.99	$27.83B	0.54	1.05 million shs	919,588 shs
GH Guardant Health	$178.80 -3.5%	$169.71	$74.55 ▼ $191.05	$24.87B	1.58	1.79 million shs	1.50 million shs
HIMS Hims & Hers Health	$27.59 -7.0%	$29.04	$13.74 ▼ $48.34	$6.92B	2.44	9.80 million shs	10.84 million shs
TEM Tempus AI	$72.22 -7.2%	$70.69	$40.77 ▼ $90.53	$14.05B	3.54	6.20 million shs	10.43 million shs

10 Best Stocks to Own in Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	-0.42%	+4.30%	+7.93%	+8.00%	+44.01%
GH Guardant Health	-3.51%	+5.75%	+0.25%	+10.38%	+147.41%
HIMS Hims & Hers Health	-7.04%	-0.39%	-7.30%	-0.71%	-40.74%
TEM Tempus AI	-7.22%	+6.82%	-11.82%	+64.62%	-18.71%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGX Quest Diagnostics	2.56	Moderate Buy	$248.70	-1.26% Downside
GH Guardant Health	2.96	Moderate Buy	$191.00	6.82% Upside
HIMS Hims & Hers Health	2.13	Hold	$32.43	17.55% Upside
TEM Tempus AI	2.41	Hold	$72.47	0.35% Upside

Current Analyst Ratings Breakdown

Latest HIMS, DGX, GH, and TEM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/27/2026	GH Guardant Health	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$195.00 ➝ $210.00
10/26/2026	TEM Tempus AI	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$66.00 ➝ $68.00
10/26/2026	TEM Tempus AI	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$80.00
10/23/2026	DGX Quest Diagnostics	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$262.00
10/23/2026	TEM Tempus AI	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$75.00
10/22/2026	GH Guardant Health	Roth Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$200.00
10/22/2026	GH Guardant Health	Roth Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$200.00
10/21/2026	DGX Quest Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Buy (A) ➝ Buy (A+)
10/19/2026	DGX Quest Diagnostics	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Neutral	$250.00
10/15/2026	GH Guardant Health	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/14/2026	TEM Tempus AI	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Neutral	$45.00 ➝ $70.00

(Data available from 10/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGX Quest Diagnostics	$11.04B	2.51	$15.11 per share	16.67	$72.26 per share	3.49
GH Guardant Health	$982.02M	24.43	N/A	N/A	($0.79) per share	-226.33
HIMS Hims & Hers Health	$2.58B	2.50	$0.78 per share	35.45	$2.38 per share	11.59
TEM Tempus AI	$1.43B	9.10	N/A	N/A	$2.76 per share	26.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGX Quest Diagnostics	$992M	$10.04	25.09	21.18	2.26	9.53%	16.21%	7.41%	N/A
GH Guardant Health	-$416.28M	-$3.49	N/A	N/A	N/A	-38.33%	N/A	-25.40%	11/5/2026 (Confirmed)
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	62.70	N/A	-5.51%	-6.51%	-1.20%	11/9/2026 (Estimated)
TEM Tempus AI	-$245.03M	-$1.44	N/A	N/A	N/A	-17.77%	-50.28%	-10.33%	11/2/2026 (Confirmed)

Latest HIMS, DGX, GH, and TEM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/9/2026	Q3 2026	HIMS Hims & Hers Health	$0.0566	N/A	N/A	N/A	$892.88 million	N/A
11/5/2026	Q3 2026	GH Guardant Health	-$0.75	N/A	N/A	N/A	$350.72 million	N/A
11/2/2026	Q3 2026	TEM Tempus AI	-$0.0876	N/A	N/A	N/A	$409.39 million	N/A
10/22/2026	Q3 2026	DGX Quest Diagnostics	$2.87	$3.00	+$0.13	$2.78	$3.05 billion	$3.10 billion
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0498	-$0.37	-$0.3202	-$0.37	$698.90 million	$753.21 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGX Quest Diagnostics	$3.44	1.37%	+7.34%	34.26%	14 Years
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
TEM Tempus AI	N/A	N/A	N/A	N/A	N/A

Latest HIMS, DGX, GH, and TEM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2026	DGX Quest Diagnostics	quarterly	$0.86	1.51%	10/6/2026	10/6/2026	10/21/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGX Quest Diagnostics	0.70	1.70	1.58
GH Guardant Health	N/A	4.03	3.71
HIMS Hims & Hers Health	4.21	0.93	0.87
TEM Tempus AI	3.06	3.30	3.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DGX Quest Diagnostics	88.06%
GH Guardant Health	92.60%
HIMS Hims & Hers Health	63.52%
TEM Tempus AI	24.22%

Insider Ownership

Company	Insider Ownership
DGX Quest Diagnostics	0.88%
GH Guardant Health	5.60%
HIMS Hims & Hers Health	11.76%
TEM Tempus AI	24.26%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DGX Quest Diagnostics	57,000	110.02 million	109.05 million	Optionable
GH Guardant Health	2,506	134.20 million	126.68 million	Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
TEM Tempus AI	3,800	180.44 million	136.66 million	Optionable

HIMS, DGX, GH, and TEM Headlines

Recent News About These Companies

TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?

October 30 at 11:16 AM | zacks.com

Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Stock

October 30 at 5:07 AM | insidertrades.com

Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Stock

October 29 at 5:07 PM | marketbeat.com

Artificial Intelligence Stocks To Research - October 28th

October 28 at 12:03 PM | marketbeat.com

Tempus AI (NASDAQ:TEM) Stock Jumps 5.3% - Time to Buy?

October 28 at 12:00 PM | marketbeat.com

Pathos Ai Enters Drug Development Collaboration with Bristol Myers Squibb and Tempus Ai

October 28 at 10:13 AM | pharmexec.comP

Can You Still Buy Tempus AI Stock Today?

October 28 at 10:13 AM | finance.yahoo.com

Tempus AI (NASDAQ:TEM) Shares Cross Above 50 Day Moving Average - Here's Why

October 28 at 4:59 AM | marketbeat.com

Tempus AI (TEM) Could Be 5% Undervalued After Bristol Myers And Pathos Deals

October 27, 2026 | finance.yahoo.com

Tempus AI Gains After New Bristol Myers Deal and EU Diagnostic Certification

October 27, 2026 | quiverquant.comQ

Promising Artificial Intelligence Stocks To Follow Today - October 27th

October 27, 2026 | marketbeat.com

The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings

October 27, 2026 | 247wallst.com

Maxi Investments CY Ltd Buys 32,500 Shares of Tempus AI, Inc. $TEM

October 27, 2026 | marketbeat.com

Pharmaceutical Executive Daily: Pathos AI Enters Collaboration with Bristol Myers Squibb

October 26, 2026 | pharmexec.comP

Tempus AI Receives EU Certification for xR RNA Sequencing

October 26, 2026 | finance.yahoo.com

Tempus AI (TEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

October 26, 2026 | zacks.com

What Happens To Tempus AI Stock If Its Cash Burn Continues?

October 26, 2026 | finance.yahoo.com

Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling

October 26, 2026 | businesswire.com

Tempus AI (NASDAQ:TEM) Earns "Buy" Rating from BTIG Research

October 26, 2026 | marketbeat.com

Tempus AI (TEM) Set to Release Earnings on Monday

October 26, 2026 | marketbeat.com

Capelight Capital Asset Management LP Purchases 50,000 Shares of Tempus AI, Inc. $TEM

October 26, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, DGX, GH, and TEM Company Descriptions

Quest Diagnostics NYSE:DGX

$251.87 -1.05 (-0.42%)

Closing price 10/30/2026 03:59 PM Eastern

Extended Trading

$251.84 -0.03 (-0.01%)

As of 10/30/2026 07:30 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Guardant Health NASDAQ:GH

$178.80 -6.51 (-3.51%)

Closing price 10/30/2026 04:00 PM Eastern

Extended Trading

$176.06 -2.75 (-1.54%)

As of 10/30/2026 07:52 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Hims & Hers Health NYSE:HIMS

$27.59 -2.08 (-7.01%)

Closing price 10/30/2026 03:59 PM Eastern

Extended Trading

$27.65 +0.06 (+0.20%)

As of 10/30/2026 07:59 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Tempus AI NASDAQ:TEM

$72.22 -5.62 (-7.22%)

Closing price 10/30/2026 04:00 PM Eastern

Extended Trading

$70.04 -2.18 (-3.01%)

As of 10/30/2026 07:59 PM Eastern

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, DGX, GH, and TEM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, DGX, GH, and TEM Earnings

Compare Dividends

Latest HIMS, DGX, GH, and TEM Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, DGX, GH, and TEM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, DGX, GH, and TEM Company Descriptions

Quest Diagnostics NYSE:DGX

Guardant Health NASDAQ:GH

Hims & Hers Health NYSE:HIMS

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools